ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Even if Chronic lymphocytic leukemia (CLL) often has an indolent behavior with good responsiveness to cytoreductive treatment, about 20% of the patients, so called "poor-risk" patients, show an aggressive course and die within a few years despite early intensive therapies. Criteria for poo...
Main Authors: | Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2010-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/174 |
Similar Items
-
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Patrizia Chiusolo, et al.
Published: (2010-05-01) -
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
by: Andrea Bacigalupo, et al.
Published: (2021-05-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Initial renal function and type of chemotherapy: impact on treatment efficacy in patients with chronic lymphocytic leukemia
by: A. K. Nikitina, et al.
Published: (2015-06-01)